Kenneth H. Pearce
Papers
1
Total Citations
11
H-Index
1
About
Kenneth H. Pearce is a medicinal chemist and chemical biologist whose research focuses on fragment-based drug discovery and the development of chemical probes for challenging therapeutic targets. His major contributions center on creating innovative computational and experimental platforms to identify small-molecule inhibitors for proteins previously considered "undruggable." Pearce's most cited work, "In silico fragment-based discovery of CIB1-directed anti-tumor agents by FRASE-bot" (2024, 11 citations), introduces FRASE-bot—a fragment-based hit-finding robot that integrates structural data with machine learning to expedite drug discovery. This approach has direct implications for oncology, particularly in targeting CIB1, a protein implicated in cancer progression. Pearce's impact lies in bridging computational chemistry and biological validation, enabling rapid identification of chemical probes that translate biological insights into therapeutic leads. His work has been recognized for its potential to streamline early-stage drug development, especially for hard-to-drug proteins, making him a key figure in modern chemical biology and translational pharmacology.
Research Focus
Key Achievements
Top Papers
- 1